Innospec (IOSP) Competitors

United Bankshares presently has a consensus price target of $47.80, indicating a potential upside of 4.60%. Given United Bankshares' stronger consensus rating and higher probable upside, equities research analysts plainly believe United Bankshares is more favorable than Innospec.

United Bankshares pays an annual dividend of $1.52 per share and has a dividend yield of 3.3%. Innospec pays an annual dividend of $1.84 per share and has a dividend yield of 1.9%. United Bankshares pays out 41.4% of its earnings in the form of a dividend. Innospec pays out 37.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. United Bankshares has increased its dividend for 26 consecutive years and Innospec has increased its dividend for 11 consecutive years. United Bankshares is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

United Bankshares has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market. Comparatively, Innospec has a beta of 0.9, suggesting that its stock price is 10% less volatile than the broader market.

In the previous week, Innospec had 2 more articles in the media than United Bankshares. MarketBeat recorded 5 mentions for Innospec and 3 mentions for United Bankshares. United Bankshares' average media sentiment score of 0.81 beat Innospec's score of 0.58 indicating that United Bankshares is being referred to more favorably in the media.

United Bankshares has higher earnings, but lower revenue than Innospec. United Bankshares is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

United Bankshares has a net margin of 27.97% compared to Innospec's net margin of 6.60%. United Bankshares' return on equity of 9.39% beat Innospec's return on equity.

70.8% of United Bankshares shares are held by institutional investors. Comparatively, 96.6% of Innospec shares are held by institutional investors. 3.2% of United Bankshares shares are held by company insiders. Comparatively, 1.5% of Innospec shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Avient pays an annual dividend of $1.10 per share and has a dividend yield of 2.7%. Innospec pays an annual dividend of $1.84 per share and has a dividend yield of 1.9%. Avient pays out 59.5% of its earnings in the form of a dividend. Innospec pays out 37.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Avient has increased its dividend for 1 consecutive years and Innospec has increased its dividend for 11 consecutive years.

95.5% of Avient shares are held by institutional investors. Comparatively, 96.6% of Innospec shares are held by institutional investors. 0.9% of Avient shares are held by insiders. Comparatively, 1.5% of Innospec shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Innospec has lower revenue, but higher earnings than Avient. Innospec is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks.

Avient currently has a consensus price target of $46.71, indicating a potential upside of 14.07%. Given Avient's stronger consensus rating and higher probable upside, equities research analysts plainly believe Avient is more favorable than Innospec.

In the previous week, Avient had 2 more articles in the media than Innospec. MarketBeat recorded 7 mentions for Avient and 5 mentions for Innospec. Avient's average media sentiment score of 0.69 beat Innospec's score of 0.58 indicating that Avient is being referred to more favorably in the media.

Avient has a beta of 1.28, suggesting that its stock price is 28% more volatile than the broader market. Comparatively, Innospec has a beta of 0.9, suggesting that its stock price is 10% less volatile than the broader market.

Innospec has a net margin of 6.60% compared to Avient's net margin of 5.10%. Avient's return on equity of 11.64% beat Innospec's return on equity.

In the previous week, Cabot had 4 more articles in the media than Innospec. MarketBeat recorded 9 mentions for Cabot and 5 mentions for Innospec. Innospec's average media sentiment score of 0.58 beat Cabot's score of 0.09 indicating that Innospec is being referred to more favorably in the news media.

93.2% of Cabot shares are held by institutional investors. Comparatively, 96.6% of Innospec shares are held by institutional investors. 3.1% of Cabot shares are held by insiders. Comparatively, 1.5% of Innospec shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Innospec has a net margin of 6.60% compared to Cabot's net margin of 5.23%. Cabot's return on equity of 20.29% beat Innospec's return on equity.

Cabot has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, Innospec has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market.

Cabot presently has a consensus target price of $87.80, suggesting a potential upside of 16.01%. Given Cabot's stronger consensus rating and higher probable upside, research analysts clearly believe Cabot is more favorable than Innospec.

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.5%. Innospec pays an annual dividend of $1.84 per share and has a dividend yield of 1.9%. Cabot pays out 53.2% of its earnings in the form of a dividend. Innospec pays out 37.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has increased its dividend for 14 consecutive years and Innospec has increased its dividend for 11 consecutive years. Cabot is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cabot has higher revenue and earnings than Innospec. Innospec is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

Innospec pays an annual dividend of $1.84 per share and has a dividend yield of 1.9%. F.N.B. pays an annual dividend of $0.52 per share and has a dividend yield of 3.0%. Innospec pays out 37.6% of its earnings in the form of a dividend. F.N.B. pays out 31.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Innospec has increased its dividend for 11 consecutive years. F.N.B. is clearly the better dividend stock, given its higher yield and lower payout ratio.

F.N.B. has a net margin of 22.29% compared to Innospec's net margin of 6.60%. Innospec's return on equity of 9.22% beat F.N.B.'s return on equity.

96.6% of Innospec shares are owned by institutional investors. Comparatively, 79.3% of F.N.B. shares are owned by institutional investors. 1.5% of Innospec shares are owned by company insiders. Comparatively, 1.5% of F.N.B. shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

F.N.B. has higher revenue and earnings than Innospec. F.N.B. is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

Innospec has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market. Comparatively, F.N.B. has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market.

F.N.B. has a consensus target price of $20.58, indicating a potential upside of 19.19%. Given F.N.B.'s stronger consensus rating and higher possible upside, analysts clearly believe F.N.B. is more favorable than Innospec.

In the previous week, Innospec had 2 more articles in the media than F.N.B.. MarketBeat recorded 5 mentions for Innospec and 3 mentions for F.N.B.. Innospec's average media sentiment score of 0.58 beat F.N.B.'s score of 0.12 indicating that Innospec is being referred to more favorably in the media.